Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium

BACKGROUND: Erythropoietin possesses cellular protection properties. The aim of the present study was to test the hypothesis that in situ expression of recombinant human erythropoietin (rhEPO) would improve tissue repair in rat after myocardial infarction (MI). METHODS AND RESULTS: RhEPO-producing c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ruvinov, Emil, Sharabani-Yosef, Orna, Nagler, Arnon, Einbinder, Tom, Feinberg, Micha S, Holbova, Radka, Douvdevani, Amos, Leor, Jonathan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2585557/
https://ncbi.nlm.nih.gov/pubmed/19014419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-1536-1-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados